- Home
- OCCIN vs CRL Comparison
OCCIN vs CRL Comparison
Compare OCCIN & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCIN
- CRL
- Stock Information
- Founded
- OCCIN N/A
- CRL 1947
- Country
- OCCIN United States
- CRL United States
- Employees
- OCCIN N/A
- CRL N/A
- Industry
- OCCIN Trusts Except Educational Religious and Charitable
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- OCCIN Finance
- CRL Health Care
- Exchange
- OCCIN Nasdaq
- CRL Nasdaq
- Market Cap
- OCCIN N/A
- CRL 7.1B
- IPO Year
- OCCIN N/A
- CRL 2000
- Fundamental
- Price
- OCCIN $24.28
- CRL $158.20
- Analyst Decision
- OCCIN
- CRL Buy
- Analyst Count
- OCCIN 0
- CRL 14
- Target Price
- OCCIN N/A
- CRL $184.85
- AVG Volume (30 Days)
- OCCIN N/A
- CRL 804.7K
- Earning Date
- OCCIN N/A
- CRL 08-06-2025
- Dividend Yield
- OCCIN N/A
- CRL N/A
- EPS Growth
- OCCIN N/A
- CRL N/A
- EPS
- OCCIN N/A
- CRL N/A
- Revenue
- OCCIN N/A
- CRL $4,022,597,000.00
- Revenue This Year
- OCCIN N/A
- CRL N/A
- Revenue Next Year
- OCCIN N/A
- CRL $2.49
- P/E Ratio
- OCCIN N/A
- CRL N/A
- Revenue Growth
- OCCIN N/A
- CRL N/A
- 52 Week Low
- OCCIN N/A
- CRL $91.86
- 52 Week High
- OCCIN N/A
- CRL $254.15
- Technical
- Relative Strength Index (RSI)
- OCCIN 58.84
- CRL 57.66
- Support Level
- OCCIN $24.21
- CRL $152.73
- Resistance Level
- OCCIN $24.30
- CRL $168.12
- Average True Range (ATR)
- OCCIN 0.04
- CRL 5.02
- MACD
- OCCIN 0.01
- CRL 0.13
- Stochastic Oscillator
- OCCIN 92.00
- CRL 47.51
About OCCIN OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation primarily through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.